DONNA STUBBS: Open Payments
NPI 1538134705 · EASTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 34 payments from 12 companies in 2025. Trend: 2023 $1,160 · 2024 $1,077 · 2025 $697
Food & beverage: $697
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 13 | $137 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $129 |
| Alexion Pharmaceuticals, Inc. | 1 | $113 |
| ABBVIE INC. | 4 | $86 |
| Endo USA, Inc. | 3 | $53 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $50 |
| Boston Scientific Corporation | 1 | $28 |
| Calyxo, Inc. | 1 | $25 |
| UROGEN PHARMA, INC. | 1 | $23 |
| Ferring Pharmaceuticals Inc. | 1 | $20 |
Products named: GEMTESA, Nubeqa, BOTOX, AVEED, PYLARIFY, LUPRON DEPOT, AMS 700, CVAC ASPIRATION SYSTEM.
Industry payments across MD — which companies pay providers there.
